Breakthrough T1D NorCal Chapter January 2024 Newsletter
JDRF’s Top Ten Advances of 2023 We have many reasons to celebrate in the type 1 diabetes (T1D) community and…
Breakthrough T1D NorCal November 2023 Newsletter
Breakthrough T1D is Forward As 1 for National Diabetes Awareness Month November marks National Diabetes Awareness Month (NDAM), a time…
Breakthrough T1D NorCal October 2023 Newsletter
Breakthrough T1D One Walk, NorCal Contest Alert! Become an Instant V1P V1P status is awarded to Breakthrough T1D One Walk participants who…
Breakthrough T1D NorCal August 2023 Newsletter
Introducing our 2023 JDRF One Walk, NorCal Corporate Chair: Al Williams of Chevron We’re thrilled to announce our Corporate Chair for the 2023 JDRF One Walk, NorCal:…
Breakthrough T1D NorCal July 2023 Newsletter
Top Type 1 Diabetes (T1D) Advances of Fiscal Year 2023 Looking back at Fiscal Year 2023, there is much to…
Breakthrough T1D NorCal June 2024 Newsletter
FDA Clears a New Artificial Pancreas System The U.S. Food and Drug Administration (FDA) cleared the iLet® Insulin-Only Bionic…
Breakthrough T1D NorCal May 2023 Newsletter
Breakthrough T1D Collaboration Leads to Next-Generation Cell Therapy Research JDRF is committed to supporting the development of cell replacement therapies that…
Breakthrough T1D NorCal April 2023 Newsletter
Breakthrough T1D Northern California Advocates to be Honored at 2023 Tee to Table Event We’re excited to honor all Breakthrough…
Breakthrough T1D NorCal March 2023 Newsletter
New Clinical Trial Finds Varapamil Slows T1D Progression in Newly Diagnosed Youth A new Breakthrough T1D-funded clinical trial suggests a…
Breakthrough T1D NorCal February 2023 Newsletter
FDA Authorizes Tidepool Loop, an Automated Insulin Dosing App Last month, the U.S. Food & Drug Administration (FDA) authorized the…